The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Effects of state surveillance on new post-hospitalization benzodiazepine use.
Anita K Wagner; Stephen B Soumerai; Fang Zhang; Connie Mah; Linda Simoni-Wastila; Leon Cosler; Thomas Fanning; Peter Gallagher; Dennis Ross-Degnan (Profiled Author: Linda Jean Simoni-Wastila)
Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, 133 Brookline Avenue, 6th Floor, Boston, MA 02215, USA. email@example.com
International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua 2003;15(5):423-31.
BACKGROUND: Benzodiazepines (BZD) effectively treat anxiety and insomnia accompanying major health events, including hospitalizations. Prescribing regulations to decrease BZD misuse may negatively impact therapeutic uses. OBJECTIVE: To assess the impact of a Triplicate Prescription Program (TPP) on initiation of post-hospitalization BZD prescribing, both overall and among cardiac and cancer patients in the United States. DESIGN: Interrupted time-series of post-hospitalization BZD dispensing events to enrollees in the US Medicaid program in the states of New York (intervention group) and New Jersey (control group), before and after implementation of a TPP. STUDY PARTICIPANTS: Community-dwelling Medicaid enrollees in New York State (n = 67 962) and New Jersey (n = 71 701), hospitalized between 1 January 1988 and 30 November 1990. INTERVENTION: The New York State TPP, implemented on 1 January 1989, requires physicians to prescribe BZD on triplicate prescription forms for state surveillance. OUTCOME MEASURES: Rates and duration of new post-hospitalization use of BZD and substitute medications. RESULTS: Overall, a sudden and sustained 63.5% decrease [95% confidence interval (CI) -58.6% to -68.3%] in new post-hospitalization BZD dispensing-from a baseline rate of 44 discharges with BZD dispensing per 1000 discharges per month-followed the TPP in New York State, without discontinuity in the control state. Patients hospitalized for acute ischemic cardiac events experienced a 72.5% reduction (95% CI -55.5% to -89.4%), and cancer patients a 69.4% reduction (95% CI -36.7% to -100.0%). The TPP did not preferentially reduce BZD use lasting >2 months. Increased substitute use did not offset reductions in BZD use. CONCLUSIONS: By decreasing new short-term post-hospitalization BZD use, the New York State TPP also had unintended effects.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Linda Simoni-Wastila; Dennis Ross-Degnan; Connie Mah; Xiaoming Gao; Jeffrey Brown; Leon E Cosler; Thomas Fanning; Peter Gallagher; Carl Salzman; Stephen B SoumeraiClinical therapeutics 2004;26(2):322-36.
Dennis Ross-Degnan; Linda Simoni-Wastila; Jeffrey S Brown; Xiaoming Gao; Connie Mah; Leon E Cosler; Thomas Fanning; Peter Gallagher; Carl Salzman; Richard I Shader; et al.International journal of psychiatry in medicine 2004;34(2):103-23.
B Stuart; B A Briesacher; F Ahern; D Kidder; C Zacker; G Erwin; D Gilden; C FahlmanHealth care financing review 1999;20(3):63-78.
Appears in this Publication
Author of this Publication